Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry disease

Daniele Masarone1, Giovanni Duro2, Santo Dellegrottaglie3

  • 1Division of Cardiology Second University of Naples - AO dei Colli, Presidio Monaldi, Naples, 80121, Italy.

Future Cardiology
|September 23, 2017
PubMed

Insights

Anderson-Fabry disease (AFD), a genetic disorder affecting multiple organs, can lead to severe cardiac issues. Patients with advanced cardiac involvement may benefit from an implantable cardioverter defibrillator to prevent sudden cardiac death.

Area of Science:

  • Genetics and rare diseases
  • Cardiology
  • Lysosomal storage disorders

Background:

  • Anderson-Fabry disease (AFD) is an inherited lysosomal storage disorder.
  • It results from deficient α-galactosidase A activity, impacting multiple organ systems.
  • Cardiac manifestations are common and can be severe.

Observation:

  • A specific case of AFD with isolated cardiac involvement is presented.
  • The patient exhibited symptoms necessitating close cardiac monitoring.
  • Progressive cardiac dysfunction posed a high risk for life-threatening arrhythmias.

Findings:

  • Left ventricular hypertrophy, valve thickening, and conduction disturbances are key cardiac features of AFD.
  • Advanced AFD cardiac disease can lead to myocardial fibrosis and sudden cardiac death.
  • Implantation of an implantable cardioverter defibrillator (ICD) was performed due to high arrhythmic event risk.

Implications:

  • Patients with advanced cardiac AFD may constitute a distinct subgroup requiring ICDs.
  • ICDs can serve as a primary prevention strategy for sudden cardiac death in these patients.
  • This case highlights the importance of recognizing and managing cardiac complications in AFD.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
550
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
628
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
634
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
675
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
510
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
605